Bristol Myers Squibb Stock Story
BMY Stock | USD 48.30 0.46 0.96% |
Slightly above 56% of Bristol Myers' investor base is looking to short. The analysis of overall sentiment of trading Bristol Myers Squibb stock suggests that many investors are alarmed at this time. Bristol Myers' investor sentiment overview provides quick insight into current market opportunities from investing in Bristol Myers Squibb. The current market sentiment, together with Bristol Myers' historical and current headlines, can help investors time the market. In addition, many technical investors use Bristol Myers Squibb stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Bristol Myers stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bristol daily returns and investor perception about the current price of Bristol Myers Squibb as well as its diversification or hedging effects on your existing portfolios.
Bristol |
Requested story not found. it has been either deleted or moved. View all stories for Bristol Myers Squibb.
Bristol Myers Latest Timeline
Bristol Myers Squibb is traded for 48.30. The company reported the last year's revenue of 45.01 B. Total Income to common stockholders was 8.04 B with profit before taxes, overhead, and interest of 36.38 B.Check out Bristol Myers Hype Analysis, Bristol Myers Correlation and Bristol Myers Performance. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.86 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.